The management of NSAID gastropathy

Baillière's Clinical Rheumatology - Tập 4 - Trang 269-291 - 1990
John M. Howard, Nicole G.H. Le Riche

Tài liệu tham khảo

Agrawal, 1985, Healing of benign gastric ulcer. A placebo-controlled comparison of two dosage regimens of misoprostol, a synthetic analog of prostaglandin E1, Digestive Diseases and Sciences, 30, 164S, 10.1007/BF01309404 Allen, 1980, Mucus and bicarbonate secretion in the stomach and their possible role in mucosal protection, Gut, 21, 249, 10.1136/gut.21.3.249 Armstrong, 1987, Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration, Gut, 28, 527, 10.1136/gut.28.5.527 Bahari, 1982, Demonstration of a pH gradient across the mucus layer on the surface of human gastric mucosa in vitro, Gut, 23, 513, 10.1136/gut.23.6.513 Bardhan, 1986, A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers, Journal of Clinical Gastroenterology, 8, 408, 10.1097/00004836-198608000-00005 Baum, 1985, Utilization of nonsteroidal antiinflammatory drugs, Arthritis and Rheumatism, 28, 686, 10.1002/art.1780280613 Berkowitz, 1987, Ranitidine protects against gastroduodenal mucosal damage associated with chronic aspirin therapy, Archives of Internal Medicine, 147, 2137, 10.1001/archinte.1987.00370120073014 Bijlsma, 1988, Treatment of endoscopy-negative NSAID-induced upper gastrointestinal symptoms with cimetidine: an international multicenter collaborative study, Alimentary Pharmacology and Therapeutics, 2S, 75 Boyd, 1979, High concentrations of glutathione in glandular stomach-possible implications for carcinogenesis, Science, 205, 1010, 10.1126/science.572989 Brand, 1985, Misoprostol, a synthetic PGE1 analog, in the treatment of duodenal ulcers. A multicenter double-blind study, Digestive Diseases and Sciences, 30, 147S, 10.1007/BF01309402 Caldwell, 1987, Sucralfate treatment of nonsteroidal antiinflammatory drug-induced gastrointestinal symptoms and mucosal damage, American Journal of Medicine, 83, 74, 10.1016/0002-9343(87)90832-1 Carson, 1987, The relative gastrointestinal toxicity of the non-steroidal anti-inflammatory drugs, Archives of Internal Medicine, 147, 1054, 10.1001/archinte.1987.00370060050010 Carson, 1987, The association of non-steroidal antiinflammatory drugs with upper gastrointestinal bleeding, Archives of Internal Medicine, 147, 85, 10.1001/archinte.1987.00370010087021 Chalmers, 1988, Meta-analysis of randomized controlled trials as a method of estimating rare complications of non-steroidal anti-inflammatory drug therapy, Alimentary Pharmacology and Therapeutics, 2, 9, 10.1111/j.1365-2036.1988.tb00761.x Collier, 1985, Non-steroidal anti-inflammatory drugs and peptic ulcer perforation, Gut, 26, 359, 10.1136/gut.26.4.359 Cox, 1987, Non-steroidal anti-inflammatories: outpatient audit of patient preferences and side-effects in different diseases, 137 Croker, 1980, Cimetidine for peptic ulcer in patients with arthritis, Annals of Rheumatic Disease, 39, 275, 10.1136/ard.39.3.275 CSM, 1986, Committee on Safety of Medicines Update: Non-steroidal anti-inflammatory drugs and serious gastrointestinal adverse reactions—2, British Medical Journal, 292, 1190, 10.1136/bmj.292.6529.1190 Daneshmend, 1990, Abolition by omeprazole of aspirin induced gastric mucosal injury in man, Gut, 31, 514, 10.1136/gut.31.5.514 Domschke, 1978, Prostaglandin-stimulated gastric mucus secretion in man, Acta Hepatogastroenterology, 25, 292 Doube, 1988, Non-steroidal anti-inflammatory drug-induced dyspepsia—is Campylobacter pyloridis implicated?, British Journal of Rheumatology, 27, 110, 10.1093/rheumatology/27.2.110 Duggan, 1986, Peptic ulcer and non-steroidal antiinflammatory agents, Gut, 27, 929, 10.1136/gut.27.8.929 Ehsanullah, 1988, NSAID-induced gastroduodenal damage: effect of ranitidine prophylaxis, Gastroenterology, 94, A111 Euler, 1990, A report of three multiclinic trials evaluating arboprostil in arthritic patients with ASA/NSAID gastric mucosal damage, Gastroenterology, 98, 1549, 10.1016/0016-5085(90)91089-O Fries, 1989, Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use, Gastroenterology, 96, 674, 10.1016/S0016-5085(89)80061-7 Garner, 1978, Mechanisms of action of aspirin on the gastric mucosa of the guinea pig, Acta Physiologica Scandinavica, 101 Gerber, 1981, Healing of peptic ulcers during continuing anti-inflammatory drug therapy in rheumatoid arthritis, Journal of Clinical Gastroenterology, 3, 7, 10.1097/00004836-198103000-00002 Graham, 1986, Aspirin and the stomach, Annals of Internal Medicine, 104, 390, 10.7326/0003-4819-104-3-390 Graham, 1983, Gastric adaptation with aspirin administration in man, Digestive Diseases and Sciences, 28, 1, 10.1007/BF01393353 Graham, 1988, Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial, Lancet, ii, 1277, 10.1016/S0140-6736(88)92892-9 Griffin, 1988, Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons, Archives of Internal Medicine, 109, 359 Guth, 1984, Local metabolism and circulation in mucosal defense, 235 Hawkey, 1986, Prostaglandins for peptic ulcer: a promise unfulfilled, Lancet, ii, 1084, 10.1016/S0140-6736(86)90478-2 Hills, 1983, Gastric mucosal barrier: hydrophobic lining to the lumen of the stomach, American Journal of Physiology (Gastrointestinal and Liver Physiology), 244, G561-568 Hingson, 1971, Effect of aspirin and related compounds on the fine structure of mouse gastric mucosa, Gastroenterology, 61, 156, 10.1016/S0016-5085(19)33594-2 Howard, 1985, Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and Ranitidine in the Zollinger-Ellison syndrome, Gastroenterology, 88, 1026, 10.1016/S0016-5085(85)80024-X Husby, 1986, A double-blind multi-centre trial of piroxicam and naproxen in osteoarthritis, Clinical Rheumatology, 5, 84, 10.1007/BF02030974 Inman, 1985, Comparative study of five NSAIDs, PEM News, 3, 3 Jaszweski, 1989, Persistence of gastric ulcers caused by plain aspirin or nonsteroidal anti-inflammatory agents in patients treated with a combination of cimetidine, antacids and enteric-coated aspirin, Digestive Diseases and Sciences, 34, 1361, 10.1007/BF01538069 Jick, 1987, Non-steroidal anti-inflammatory drugs and hospital admission for perforated peptic ulcer, Lancet, ii, 380, 10.1016/S0140-6736(87)92393-2 Jiranek, 1989, Misoprostol reduces gastroduodenal injury from one week of aspirin: an endoscopic study, Gastroenterology, 96, 656, 10.1016/S0016-5085(89)80062-9 Kauffman, 1989, Aspirin-induced gastric mucosal injury: lessons learned from animal models, Gastroenterology, 96, 606, 10.1016/S0016-5085(89)80056-3 Kauffman, 1979, Effects of prostacyclin and a stable analogue, 6 beta-PGI1 on gastric acid secretion, mucosal blood flow, and blood pressure in conscious dogs, Gastroenterology, 77, 1301, 10.1016/0016-5085(79)90171-9 Kimmey, 1988, Role of H2-receptor blockers in the prevention of gastric injury resulting from nonsteroidal anti-inflammatory agents, American Journal of Medicine, 84, 49, 10.1016/0002-9343(88)90254-9 Langman, 1989, Epidemiologic evidence on the association between peptic ulceration and antiinflammatory drug use, Gastroenterology, 96, 640, 10.1016/S0016-5085(89)80060-5 Lanza, 1988, Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosl injury to the stomach and duodenum, Gastroenterology, 95, 289, 10.1016/0016-5085(88)90482-9 Lanza, 1988, A multi-center double-blind comparison of ranitidine vs placebo in the prophylaxis of nonsteroidal antiinflammatory drug (NSAID) induced lesions in gastric and duodenal mucosae, Gastroenterology, 94, A250 Larkai, 1987, Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use, American Journal of Gastroenterology, 82, 1152 Larkai, 1989, Dyspepsia in NSAID users: the size of the problem, Journal of Clinical Gastroenterology, 11, 158, 10.1097/00004836-198904000-00009 Lichtenberger, 1985, Effect of 16,16-dimethyl prostaglandin E2 on the surface hydrophobicity of aspirin-treated canine gastric mucosa, Gastroenterology, 88, 308, 10.1016/S0016-5085(85)80185-2 Lind, 1983, Effects of omeprazole—a gastric proton pump inhibitor—on pentagastrin stimulated acid secretion in man, Gut, 24, 270, 10.1136/gut.24.4.270 Manniche, 1987, Randomized study of the influence of non-steroidal anti-inflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease, Gut, 28, 226, 10.1136/gut.28.2.226 McIntosh, 1985, Environmental factors in aetiology of chronic gastric ulcer: a case control study of exposure variables before the first symptoms, Gut, 26, 789, 10.1136/gut.26.8.789 McQueen, 1983, Gastric and duodenal surface mucus gel thickness in rat: effects of prostaglandins and damaging agents, American Journal of Physiology (Gastrointestinal and Liver Physiology), 245, G388, 10.1152/ajpgi.1983.245.3.G388 Meyer, 1986, Effects of aspirin on tight junction structure of the canine gastric mucosa, Gastroenterology, 91, 351, 10.1016/0016-5085(86)90568-8 Muller, 1986, Akute schadigung der magen schleinhaut durch acetylsalicylsaure. Eine endoskopische vergleichsstudie am menschen mit oral virksamen prostaglandin-analoga, omeprazol und ranitidine, Arzneimittelforsch, 36, 265 Murray, 1974, Effect of several drugs on gastric potential difference in man, British Medical Journal, 1, 19, 10.1136/bmj.1.5896.19 O'Laughlin, 1982, Resistance to medical therapy of gastric ulcers in rheumatic disease patients taking aspirin, Digestive Diseases and Sciences, 27, 976, 10.1007/BF01391742 Pincus, 1986, Taking mortality in rheumatoid arthritis seriously-predictive markers, socioeconomic status and comorbidity, Journal of Rheumatology, 13, 841 Rachmilewitz, 1986, Cimetidine significantly decreases indomethacin induced gastroduodenal mucosal damage, Gastroenterology, 90, 1596 Redfern, 1989, Role of endogenous prostaglandins in preventing gastrointestinal ulceration: induction of ulcers by antibodies to prostaglandins, Gastroenterology, 96, 596, 10.1016/S0016-5085(89)80055-1 Robert, 1979 Robert, 1983, Mild irritants prevent gastric necrosis through ‘adaptive cytoprotection’ mediated by prostaglandins, American Journal of Physiology (Gastrointestinal and Liver Physiology), 245, G113, 10.1152/ajpgi.1983.245.1.G113 Roth, 1987, Cimetidine therapy in nonsteroidal anti-inflammatory drug gastropathy. Double-blind long-term evaluation, Archives of Internal Medicine, 147, 1798, 10.1001/archinte.1987.00370100112018 Rutten, 1983, Morphology and electrophysiology of guinea pig gastric mucosal repair in vitro, American Journal of Physiology (Gastrointestinal and Liver Physiology), 244, G171, 10.1152/ajpgi.1983.244.2.G171 Sandmark, 1988, Omeprazole or ranitidine in the treatment of reflux esophagitis: results of a double-blind, randomized, Scandinavian multicenter study, Scandinavian Journal of Gastroenterology, 23, 625, 10.3109/00365528809093923 Sarosiek, 1986, Effect of acetylsalicylic acid on gastric mucin viscosity, permeability to hydrogen ion, and susceptibility to pepsin, Biochemical Pharmacology, 35, 4281, 10.1016/0006-2952(86)90708-2 Schoen, 1989, Mechanisms of non-steroidal anti-inflammatory drug-induced gastric damage, American Journal of Medicine, 86, 449, 10.1016/0002-9343(89)90344-6 Shepherd, 1989, Effect of sucralfate and cimetidine on rheumatoid patients with active gastroduodenal lesions who are taking nonsteroidal anti-inflammatory drugs, American Journal of Medicine, 86, 49, 10.1016/0002-9343(89)90157-5 Silen, 1985, Mechanisms for rapid re-epithelialization of the gastric mucosal surface, Annual Review of Physiology, 47, 217, 10.1146/annurev.ph.47.030185.001245 Silvoso, 1979, Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy, Annals of Internal Medicine, 91, 517, 10.7326/0003-4819-91-4-517 Somerville, 1986, Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer, Lancet, i, 462, 10.1016/S0140-6736(86)92927-2 Stern, 1987, Protective effect of sucralfate against aspirin-induced damage to the human gastric mucosa, American Journal of Medicine, 83, 83, 10.1016/0002-9343(87)90833-3 Stiel, 1986, Protective effect of enprostil against aspirin-induced gastroduodenal mucosal injury in man, American Journal of Medicine, 81, 54, 10.1016/S0002-9343(86)80012-2 Szabo, 1989, Pathways of gastrointestinal protection and repair: mechanisms of action of sucralfate, American Journal of Medicine, 86, 23, 10.1016/0002-9343(89)90153-8 Tarnawski, 1987, Cytoprotective drugs. Focus on essential fatty acids and sucralfate, Scandinavian Journal of Medicine, 22, 39 Thomson, 1986, American Journal of Medicine, 81, 59, 10.1016/S0002-9343(86)80013-4 Vantrappen, 1982, Effect of 15(R)-15-methylprostaglandin E2 (arbaprostil) on the healing of duodenal ulcer. A double-blind multicenter study, Gastroenterology, 83, 357, 10.1016/S0016-5085(82)80328-4 Walan, 1989, Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer, New England Journal of Medicine, 320, 69, 10.1056/NEJM198901123200201 Wu, 1984, Does sucralfate protect against aspirin induced mucosal lesions? Yes and no!, Gastroenterology, 86, 1303